drugset / Trial / NCT00256347

Analgesic Tolerance to Repeated Doses of Subcutaneous Morphine

NCT00256347

RandomizedCrossoverDouble-blind

Summary

30 healthy volunteers will be enrolled in this 6-session study. The first visit will be a screening/orientation session. The next 5 visits will be (full day) outpatient sessions taking place Monday through Friday during one week. All full day visits will be drug administration sessions with subjects randomized to one of two groups. The primary purpose is to investigate the time course of development of analgesic tolerance (loss of pain relieving effect) to morphine on experimentally produced skin tenderness in healthy volunteers.

Timeline

Start
2005-03
Primary completion
2006-12
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 8 mg Intramuscular

Indications

No indication recorded.